ALAMEDA, Calif., Dec. 5, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company innovating therapeutics for neurological care, announced today that Avigen will present information on the company’s development programs and product pipeline at two upcoming healthcare conferences:
